143 related articles for article (PubMed ID: 33309455)
21. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.
Mezei AK; Pedersen HN; Sy S; Regan C; Mitchell-Foster SM; Byamugisha J; Sekikubo M; Armstrong H; Rawat A; Singer J; Ogilvie GS; Kim JJ; Campos NG
BMJ Open; 2018 Jun; 8(6):e020484. PubMed ID: 29895648
[TBL] [Abstract][Full Text] [Related]
22. Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.
Sekiguchi M; Igarashi A; Matsuda T; Matsumoto M; Sakamoto T; Nakajima T; Kakugawa Y; Yamamoto S; Saito H; Saito Y
Jpn J Clin Oncol; 2016 Feb; 46(2):116-25. PubMed ID: 26685321
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC).
Tsiachristas A; Gittins M; Kitchener H; Gray A
J Med Screen; 2018 Jun; 25(2):99-109. PubMed ID: 28530515
[TBL] [Abstract][Full Text] [Related]
24. Cancer Screening Test Use-U.S., 2019.
Sabatino SA; Thompson TD; White MC; Shapiro JA; Clarke TC; Croswell JM; Richardson LC
Am J Prev Med; 2022 Sep; 63(3):431-439. PubMed ID: 35469700
[TBL] [Abstract][Full Text] [Related]
25. Cost-Effectiveness of Colorectal Cancer Screening Strategies-A Systematic Review.
Ran T; Cheng CY; Misselwitz B; Brenner H; Ubels J; Schlander M
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):1969-1981.e15. PubMed ID: 30659991
[TBL] [Abstract][Full Text] [Related]
26. Costs and Cost-Effectiveness of Targeted, Personalized Risk Information to Increase Appropriate Screening by First-Degree Relatives of People With Colorectal Cancer.
Reeves P; Doran C; Carey M; Cameron E; Sanson-Fisher R; Macrae F; Hill D
Health Educ Behav; 2019 Oct; 46(5):798-808. PubMed ID: 30857431
[No Abstract] [Full Text] [Related]
27. Cost-effectiveness of colorectal cancer screening strategies: A systematic review.
Gheysariyeha F; Rahimi F; Tabesh E; Hemami MR; Adibi P; Rezayatmand R
Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13673. PubMed ID: 35974390
[TBL] [Abstract][Full Text] [Related]
28. Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History.
Cenin DR; Naber SK; de Weerdt AC; Jenkins MA; Preen DB; Ee HC; O'Leary PC; Lansdorp-Vogelaar I
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):10-21. PubMed ID: 31748260
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests.
Kulasingam SL; Myers ER; Lawson HW; McConnell KJ; Kerlikowske K; Melnikow J; Washington AE; Sawaya GF
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):321-8. PubMed ID: 16449119
[TBL] [Abstract][Full Text] [Related]
30. Cost-Effectiveness of Current Colorectal Cancer Screening Tests.
Ladabaum U
Gastrointest Endosc Clin N Am; 2020 Jul; 30(3):479-497. PubMed ID: 32439083
[TBL] [Abstract][Full Text] [Related]
31. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
Charkhchi P; Schabath MB; Carlos RC
J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
[No Abstract] [Full Text] [Related]
32. VIA/VILI is more suitable for cervical cancer prevention in Chinese poverty-stricken region: a health economic evaluation.
Xie Y; Tan X; Shao H; Liu Q; Tou J; Zhang Y; Luo Q; Xiang Q
BMC Public Health; 2017 Jan; 17(1):118. PubMed ID: 28122530
[TBL] [Abstract][Full Text] [Related]
33. A systematic review of special events to promote breast, cervical and colorectal cancer screening in the United States.
Escoffery C; Rodgers KC; Kegler MC; Haardörfer R; Howard DH; Liang S; Pinsker E; Roland KB; Allen JD; Ory MG; Bastani R; Fernandez ME; Risendal BC; Byrd TL; Coronado GD
BMC Public Health; 2014 Mar; 14():274. PubMed ID: 24661503
[TBL] [Abstract][Full Text] [Related]
34. Markov's modeling for screening strategies for colorectal cancer.
Barouni M; Larizadeh MH; Sabermahani A; Ghaderi H
Asian Pac J Cancer Prev; 2012; 13(10):5125-9. PubMed ID: 23244122
[TBL] [Abstract][Full Text] [Related]
35. [Methods to increase participation in cancer screening programmes].
Giorgi Rossi P; Camilloni L; Cogo C; Federici A; Ferroni E; Furnari G; Giordano L; Grazzini G; Iossa A; Jimenez B; Palazzi M; Palazzo F; Spadea T; Senore C; Borgia P; Guasticchi G
Epidemiol Prev; 2012 Jan; 36(1 Suppl 1):1-104. PubMed ID: 22418841
[TBL] [Abstract][Full Text] [Related]
36. Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines.
Pedersen K; Burger EA; Nygård M; Kristiansen IS; Kim JJ
Eur J Cancer; 2018 Mar; 91():68-75. PubMed ID: 29335156
[TBL] [Abstract][Full Text] [Related]
37. A review of the cost-effectiveness of adult influenza vaccination and other preventive services.
Dabestani NM; Leidner AJ; Seiber EE; Kim H; Graitcer SB; Foppa IM; Bridges CB
Prev Med; 2019 Sep; 126():105734. PubMed ID: 31152830
[TBL] [Abstract][Full Text] [Related]
38. Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model.
Gomez JA; Lepetic A; Demarteau N
BMC Public Health; 2014 Nov; 14():1222. PubMed ID: 25424716
[TBL] [Abstract][Full Text] [Related]
39. Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.
Ladabaum U; Mannalithara A; Brill JV; Levin Z; Bundorf KM
Am J Gastroenterol; 2018 Dec; 113(12):1836-1847. PubMed ID: 29904156
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
